Medycyna Paliatywna

Pełna treść

3/2026 vol. 18
Artykuł przeglądowy

Sleep disturbances in pediatric palliative care: a literature review

  1. Maria Sklodowska-Curie Medical Academy in Warsaw, Warsaw, Poland

  2. University Clinical Center of the Medical University of Warsaw, Warsaw, Poland

Medycyna Paliatywna 2026; 18(3): 158–164

Data publikacji online: 2026/11/16
Plik artykułu
Sleep disturbances.pdf

Introduction

Sleep disturbances are increasingly recognized as clinically relevant symptoms in children with life-limiting and life-threatening conditions, where poor sleep may substantially increase symptom burden and impair quality of life.

Pediatric palliative care (PPC) is a comprehensive, multidisciplinary approach aimed at improving the quality of life of children with serious illnesses and their families through the prevention and relief of suffering. It addresses physical, psychological, social, and spiritual needs across the entire disease trajectory [1].

In pediatric oncology, PPC is integrated with disease-directed treatment and may be introduced early, continuing alongside curative or life-prolonging therapies [2, 3]. Integration of palliative care in pediatric oncology has been shown to improve quality of life, symptom control, and communication, benefiting both patients and their families [4].

Sleep disturbances in PPC differ substantially from those observed in adult populations due to developmental factors, communication limitations, a high prevalence of neurological impairment, and dependence on caregiver-reported observations. Recent international efforts have emphasized the need for pediatric-specific approaches to sleep assessment and management in this vulnerable population [5].

Sleep disturbances are increasingly recognized as a significant yet under-addressed problem in PPC. Despite their high prevalence and impact, evidence remains limited and fragmented, prompting recent efforts to establish international consensus recommen­dations for their assessment and management [5]. The aim of this review is to summarize current evidence on the epidemiology, clinical characteristics, and determinants of sleep disturbances in PPC, with particular emphasis on their clinical relevance and implications for management.

Epidemiology

Sleep disturbances are among the most common symptoms in PPC.

Studies indicate that sleep disorders affect approximately 45–80% of children receiving PPC.

In a structured assessment using a systematic sleep protocol, Dreier et al. [6] reported sleep disturbances in 45.6% of patients.

More recent data from a tertiary PPC unit demonstrated a prevalence of 78.26%, with insomnia and circadian rhythm disorders being the most common. Importantly, recent findings suggest that sleep disturbances in PPC may be substantially more prevalent than previously recognized, particularly in children with severe neurological impairment. The variability in prevalence reflects differences in underlying diagnoses, particularly the predominance of neurological disorders, as well as methodological heterogeneity in assessment approaches [7].

Sleep disturbances frequently coexist with other symptoms and significantly increase overall disease burden [6]. Taken together, these findings suggest that sleep disturbances are not incidental but represent a core clinical issue in PPC populations.

Material and methods

A narrative literature review was conducted to prepare this article. Electronic databases, including PubMed, Embase, Google Scholar, ResearchGate, and Scopus, were systematically searched. Articles published between 2016 and April 1, 2026 were included. The search focused on studies related to sleep disturbances, sleep assessment, and sleep management in PPC populations. The search strategy involved key words in both English and Polish, combined using Boolean operators “AND” and “OR”. The following terms were used: “children” OR “adolescents” AND “pediatric palliative care” OR “oncological disease”. Inclusion criteria comprised articles published in English or Polish with open access availability. In total, 15 studies met the inclusion criteria and were included in the review.

A large number of records were initially identified, the majority of which concerned adult populations. Given the limited availability of pediatric-specific evidence, particular emphasis was placed on studies addressing PPC from multiple clinical perspectives.

Studies were excluded if they did not specifically address pediatric populations or lacked relevance to palliative or oncological care. This selection process enabled the inclusion of literature directly applicable to the clinical context of PPC. The review was conducted as a narrative synthesis of the available literature.

Clinical characteristics

Sleep disturbances in PPC represent a heterogeneous group of disorders that differ in etiology, clinical presentation, and severity. Their characterization is particularly challenging due to the complex clinical condition of patients, frequent neurological impairment, and limited ability of many children to communicate their symptoms. This complexity reflects both the heterogeneity of underlying conditions and the unique developmental context of pediatric patients.

Although sleep disorders may be categorized according to the International Classification of Sleep Disorders (ICSD-3), PPC populations most commonly present with insomnia and circadian rhythm disturbances [6, 7].

Insomnia in this population typically manifests as difficulty initiating sleep, frequent nocturnal awakenings, reduced total sleep time, or early morning awakening. These disturbances are often persistent and may coexist with daytime symptoms such as irritability, fatigue, and decreased functional capacity.

Circadian rhythm disturbances are also frequently observed, particularly in children with severe neurological conditions. These may present as irregular sleep- wake patterns, fragmented sleep, or reversal of the sleep-wake cycle. Such disruptions are often associated with impaired regulation of endogenous biological rhythms and may be exacerbated by environmental factors and caregiving routines. Children with severe neurological impairment are particularly affected, often presenting with fragmented sleep, irregular sleep-wake cycles, and difficulty maintaining sleep [7].

Assessment of sleep disturbances in this population is further complicated by reliance on caregiver reports. Due to communication limitations, particularly in non-verbal children, sleep problems are often identified based on parental observations rather than direct patient reporting. This may lead to both underestimation and misinterpretation of symptoms.

Overall, sleep disturbances in PPC are diverse, multifactorial, and frequently atypical in presentation. Their clinical characterization requires a comprehensive and individualized approach that takes into account the underlying disease, associated symptoms, and the specific context of care. Consequently, a purely categorical classification of sleep disorders may be insufficient in PPC, and a more individualized clinical interpretation is often required.

Clinical determinants

Sleep disturbances in PPC are the result of complex interactions between multiple clinical factors. Similar to adult populations, these determinants can be grouped into several major categories. For the purpose of this review, they are classified into four main groups: disease-related factors, treatment-related factors, environmental factors, and psychosocial factors. This structured approach facilitates a better understanding of the multifactorial nature of sleep disturbances in this population.

Disease-related factors

Underlying medical conditions represent one of the primary determinants of sleep disturbances in PPC. Neurological, genetic, and metabolic conditions significantly disrupt sleep regulation and are highly prevalent in PPC populations [7].

In addition, the overall severity of illness and symptom burden contribute significantly to sleep disruption. Coexisting symptoms such as pain, dyspnea, seizures, and gastrointestinal discomfort may directly interfere with sleep initiation and maintenance, further worsening sleep quality. Thus, sleep disturbances may represent an intrinsic manifestation of the underlying disease rather than merely a secondary complication.

Treatment-related factors

Pharmacological management, which is a cor- nerstone of palliative care, is another important contributor to sleep disturbances. Children with advanced disease often receive multiple medications, including opioids and sedatives, which can negatively affect sleep architecture and contribute to insomnia [8].

Opioids, in particular, have been associated with sleep fragmentation, reduced sleep efficiency, and alterations in rapid eye movement sleep. While these medications are essential for symptom control, their potential impact on sleep should be carefully considered in clinical practice. This creates a clinical dilemma in which effective symptom control may come at the expense of sleep quality.

Environmental factors

Environmental conditions play a significant role in shaping sleep quality in children receiving palliative care, particularly in hospital settings. Hospital environments expose children to excessive noise and inappropriate light levels, which disrupt circadian rhythms and sleep continuity [9].

Frequent medical interventions, including monitoring, medication administration, and staff entries into patient rooms, further contribute to sleep fragmentation. These factors are often unavoidable but should be recognized as modifiable contributors to sleep disturbances. Importantly, these factors are potentially modifiable and therefore represent a key target for intervention.

Psychosocial factors

Psychological and emotional factors also play an important role in the development and persistence of sleep disturbances in PPC. Psychological distress, anxiety, and family burden significantly influence sleep quality. Pediatric palliative care requires a family-centered approach addressing both patient and caregiver needs [4, 10, 11].

The interaction between psychological distress and physical symptoms may further exacerbate sleep problems, creating a bidirectional relationship in which poor sleep worsens emotional well-being and vice versa. These interactions highlight the need for a holistic, patient- and family-centered approach to care.

Clinical significance

Sleep disturbances in PPC have significant clinical implications, affecting not only the child’s physical and psychological well-being but also the overall functioning of the family unit. They are associated with reduced quality of life, increased symptom burden, and impaired daily functioning [4, 6].

Sleep interacts bidirectionally with other symptoms: pain, anxiety, and fatigue worsen sleep, while poor sleep exacerbates symptom perception and emotional distress [8, 12].

Another critical aspect is the impact on caregivers and family members. Children receiving palliative care are often dependent on caregivers during the night, which leads to frequent awakenings and disrupted sleep not only for the patient but also for parents or other family members. Additionally, caregivers are significantly affected, experiencing fatigue, stress, and reduced well-being [4].

Sleep disturbances may also influence the overall course of care. Poor sleep can contribute to decreased tolerance to symptoms, impaired emotional regulation, and reduced responsiveness to therapeutic interventions. In some cases, unrecognized sleep problems may lead to unnecessary intensification of pharmacological treatment, particularly when symptoms such as irritability or agitation are misinterpreted.

In summary, sleep disturbances in PPC have wide-ranging clinical consequences, affecting patients, caregivers, and the broader care process. Their recognition and appropriate management are essential components of comprehensive palliative care. Altogether, these findings suggest that addressing sleep disturbances may have a broader impact on overall care outcomes than is often assumed.

Diagnostics

The assessment of sleep disturbances in PPC remains a significant clinical challenge due to the complexity of patients’ conditions and the lack of standardized diagnostic approaches. Despite the availability of various tools for sleep evaluation, their applicability in PPC is limited, particularly in children with severe neurological impairment or communication difficulties.

In general, diagnostic methods for sleep disturbances can be divided into two main categories: subjective and objective assessments. However, in the context of PPC, subjective methods are more commonly used due to their feasibility and lower burden for patients and caregivers.

Subjective assessment methods

Objective methods of sleep assessment include actigraphy and polysomnography. They provide more accurate data but are often difficult to implement in PPC settings [5, 8].

Polysomnography remains the gold standard for the diagnosis of sleep disorders, as it provides detailed information on sleep architecture, respiratory patterns, and neurological activity. A major limitation is the discrepancy between caregiver-reported and patient-reported outcomes, highlighting the need for improved and standardized assessment strategies [4].

In practice, objective methods are rarely used in PPC, and when applied, they are typically limited to specific clinical situations.

Limitations and challenges in pediatric palliative care

Several factors complicate the accurate assessment of sleep disturbances in PPC. First, the lack of standardized diagnostic criteria specific to PPC limits the comparability of studies and clinical evaluations. Second, the heterogeneity of patient populations and underlying conditions makes it difficult to apply uniform assessment tools.

Communication barriers represent another major challenge. Many children in PPC are non-verbal or have cognitive impairments, necessitating reliance on caregiver observations. This may lead to under-­recognition or misinterpretation of sleep problems.

Additionally, the clinical priority in palliative care is often focused on managing acute and life-threatening symptoms, which may result in sleep disturbances being overlooked or considered secondary.

Overall, the diagnosis of sleep disturbances in PPC requires a pragmatic and individualized approach. While subjective methods remain the primary tools for assessment, there is a need for the development of standardized, validated instruments tailored to this specific population.

Management

Given the multifactorial nature of sleep disturbances, management strategies must also be multidimensional. The management of sleep disturbances in PPC remains challenging due to the limited availability of evidence-based guidelines and the heterogeneity of the patient population. Current approaches are largely based on general principles of symptom control and must be individualized according to the child’s clinical condition, underlying disease, and overall goals of care.

Non-pharmacological interventions

Non-pharmacological strategies constitute the first-line approach to managing sleep disturbances in PPC, particularly due to their safety profile and feasibility. These interventions primarily focus on optimizing environmental and behavioral factors that influence sleep.

Improvement of sleep hygiene is a key component of management. This includes maintaining a regular sleep-wake schedule, minimizing nighttime disturbances, and promoting exposure to natural light during the daytime. Sleep hygiene, environmental modifications, and behavioral strategies are first-line interventions [5, 13].

Given the evidence demonstrating excessive noise and inadequate light exposure in pediatric hospital environments, targeted interventions addressing these factors may contribute to improved sleep quality. Additionally, caregiver education plays an important role in implementing consistent sleep routines and recognizing factors that may disrupt sleep.

Pharmacological management of sleep disturbances

Due to the lack of standardized recommendations and limited pediatric-specific evidence, pharmacological management should be approached with caution. Treatment decisions should take into account the potential benefits and risks, as well as the interaction with other medications commonly used in PPC.

In many cases, pharmacological interventions are directed not at sleep itself but at underlying symptoms contributing to sleep disturbances, such as pain, anxiety, or dyspnea. Effective control of these symptoms may lead to secondary improvement in sleep.

Pharmacological management of sleep disturbances in PPC remains challenging due to the limited availability of pediatric-specific evidence and the heterogeneity of patient populations. Current recommendations emphasize that pharmacological treatment should be individualized and considered primarily when non-pharmacological strategies are insufficient or when sleep disturbances substantially impair quality of life. In many cases, management should focus on treating symptoms contributing to poor sleep, such as pain, anxiety, neurological symptoms, or circadian dysregulation [5].

Among available pharmacological interventions, melatonin is considered one of the most commonly used and best-tolerated agents in pediatric sleep medicine. A meta-analysis of randomized controlled trials demonstrated that melatonin may improve sleep onset latency and increase total sleep time in children and adolescents with sleep onset insomnia, while maintaining a favorable safety profile [14]. Although evidence specific to PPC remains scarce, melatonin may be particularly beneficial in children with circadian rhythm disturbances and neurological impairment, both of which are highly prevalent in PPC populations [5, 14]. Due to its relatively low risk of adverse effects and ease of administration, melatonin may represent a reasonable first pharmacological option when behavioral and environmental interventions fail to achieve adequate symptom control.

In selected and refractory cases, more individualized pharmacological approaches may be required. Recent evidence from PPC practice described the successful home use of dexmedetomidine in children with severe neurological impairment experiencing intractable dystonia and insomnia [14]. The authors reported improvements in sleep quality and symptom control, suggesting that dexmedetomidine may represent a feasible option in highly selected patients with severe sleep disturbances unresponsive to conventional management. However, due to the limited evidence base and potential safety concerns, such interventions should be reserved for carefully monitored clinical situations [14].

Overall, pharmacological treatment of sleep disturbances in PPC should be approached cautiously and integrated into a broader, multidisciplinary symptom management strategy. Given the limited evidence specific to PPC, most current practices are extrapolated from pediatric sleep medicine, neurology, and general palliative care populations [5] (Table 1, Figure 1).

The figure summarizes the stepwise and individualized approach to pharmacological sleep management described in the current literature. Treatment should be guided by contributing symptoms and underlying clinical conditions, while pharmacological interventions remain individualized and integrated with non-pharmacological strategies [5, 14, 15].

Multidisciplinary approach

Given the multifactorial nature of sleep disturbances in PPC, a multidisciplinary approach is essential. Effective management requires collaboration between physicians, nurses, psychologists, and palliative care teams to address complex needs and support families [2, 16, 17].

Sleep disturbances should be considered within the broader context of symptom management and quality of life. Addressing physical, psychological, and environmental aspects simultaneously may improve overall outcomes and reduce the burden of sleep-related problems.

Overall, the management of sleep disturbances in PPC requires an individualized, holistic approach.

Limitations

These limitations highlight the need for cautious interpretation of the available evidence. Current research is limited by small sample sizes, heterogeneity, and lack of standardized diagnostic tools [5]. These limitations should be taken into account when interpreting the findings presented in this review.

First, the number of studies focusing specifically on pediatric populations in palliative care remains relatively small. Most available data are derived from single-center observational studies with limited sample sizes, which restricts the generalizability of results. In addition, significant heterogeneity exists across studies in terms of patient characteristics, underlying diagnoses, and care settings.

Second, the lack of standardized definitions and diagnostic criteria for sleep disturbances in PPC represents a major limitation. Different studies use various assessment tools and outcome measures, including caregiver-reported questionnaires and clinical evaluations, which makes direct comparison of results difficult. Furthermore, many of these tools have not been specifically validated for use in children with severe neurological impairment or complex medical conditions.

Another important limitation is the reliance on subjective assessment methods. Due to communication barriers in this population, sleep disturban­ces are often evaluated based on caregiver reports, which may be influenced by individual perceptions and reporting bias. Objective methods, although more accurate, are rarely used in PPC due to practical and ethical constraints.

Additionally, a substantial proportion of current knowledge is extrapolated from adult palliative care populations. While this may provide useful insights, it does not fully reflect the unique developmental, neurological, and psychosocial characteristics of pediatric patients.

Future research should focus on the development of standardized, validated tools for the assessment of sleep disturbances in PPC. There is also a need for larger, multicenter studies to better estimate prevalence and identify risk factors in diverse patient populations. Longitudinal studies would be particularly valuable in understanding the evolution of sleep disturbances over the course of illness.

Moreover, further investigation into effective management strategies is essential. Evidence-based guidelines tailored to PPC are currently lacking, and their development should be considered a priority. Addressing these gaps will be essential for advancing both research and clinical practice in this field.

Conclusions

Sleep disturbances are a common and clinically significant problem in PPC, affecting a substantial proportion of patients and contributing to the overall symptom burden. Available evidence indicates that these disturbances are multifactorial in origin, resulting from the interaction of disease-related, treatment-related, environmental, and psychosocial factors.

Despite their high prevalence and impact, sleep disturbances remain under-recognized and insufficiently addressed in clinical practice. Challenges in assessment, particularly in children with severe neurological impairment or limited communication abilities, further complicate their identification and management. As a result, sleep-related problems may be overlooked or considered secondary to other symptoms.

Sleep disturbances have important consequences not only for patients but also for their caregivers, influencing quality of life, emotional well-being, and the overall care process. Their bidirectional relationship with other symptoms highlights the need for a comprehensive and integrated approach to symptom management.

Current diagnostic and therapeutic strategies are limited by the lack of standardized tools and evidence-based guidelines tailored to PPC. Therefore, routine assessment of sleep should be incorporated into clinical practice, using feasible and patient- centered methods.

Further research is required to better understand the mechanisms underlying sleep disturbances in this population and to develop effective, individualized management strategies. Improving recognition and addressing sleep disturbances may contribute to enhanced quality of life and more comprehensive care for children receiving palliative support. Addressing sleep disturbances should be considered a key component of comprehensive PPC. Incorporating routine sleep assessment and management into PPC may represent an important step toward more holistic and patient-centered care.

Disclosures

1. Institutional review board statement: Not applicable.

2. Assistance with the article: None.

3. Financial support and sponsorship: None.

4. Conflicts of interest: None.

References

  1. Benini F, Avagnina I, Giacomelli L, Papa S, Mercante A, Peril­ongo G. Pediatric palliative care in oncology: basic principles. Cancers (Basel) 2022 A; 14: 1972.
  2. Pyke-Grimm KA, Fisher B, Haskamp A, Bell CJ, Newman AR. Pro­viding palliative and hospice care to children, adolescents and young adults with cancer. Semin Oncol Nurs 2021; 37: 151166.
  3. Cuviello A, Yip C, Battles H, Wiener L, Boss R. Triggers for palliative care referral in pediatric oncology. Cancers (Basel) 2021; 13: 1419.
  4. Kaye EC, Weaver MS, DeWitt LH, Byers E, Stevens SE, Lukow­ski J, et al. The impact of specialty palliative care in pediatric oncology: a systematic review. J Pain Symptom Manage 2021; 61: 1060-1079.e2.
  5. Mercante A, Owens J, Bruni O, Nunes ML, Gringras P, Li SX, et al. Pediatric Sleep and Palliative Care Group. International consensus on sleep problems in pediatric palliative care: pav­ing the way. Sleep Med 2024; 119: 574-583.
  6. Dreier LA, Zernikow B, Stening K, Wager J. Insights into the frequency and distinguishing features of sleep disorders in pediatric palliative care incorporating a systematic sleep protocol. Children (Basel) 2021; 8: 54.
  7. Monfort Belenguer L, Piolatti Luna A, Lázaro Carre¼o MI, Cantavella Pons T, Villar Vera C. Sleep disorders in children managed in the pediatric palliative care unit of a tertiary hos­pital. An Pediatr (Engl Ed) 2026; 104: 504084.
  8. Jakobsen G, Gjeilo KH, Hjermstad MJ, Klepstad P. An update on prevalence, assessment, and risk factors for sleep disturbances in patients with advanced cancer-implications for health care providers and clinical research. Cancers (Basel) 2022; 14: 3933.
  9. Fidler AL, Waitt J, Lehmann LE, Solet JM, Duffy JF, Gonza- lez BD, et al. Sleep and circadian disruptors: unhealthy noise and light levels for hospitalized pediatric patients. J Hosp Med 2023; 18: 999-1003.
  10. Rico-Mena P, Güeita-Rodríguez J, Martino-Alba R, Chocarro- Gonzalez L, Sanz-Esteban I, Palacios-Ce¼a D. Understanding pediatric palliative care within interdisciplinary palliative programs: a qualitative study. BMC Palliat Care 2023; 22: 80.
  11. Jeong S, Knackstedt A, Linebarger JS, Carter BS. Moral distress and pediatric palliative care. Children (Basel) 2024; 11: 751.
  12. Guiteras AF, Abelló HV, Domingo JP, Danés CF, Ripoll AR, Berger R. Palliative oncological patients with insomnia: con­cerns of the patients and their relatives’ perception. Int J Envi­ron Res Public Health 2021; 18: 8509.
  13. Wells-Di Gregorio S, Flowers S, Peng J, Marks DR, Probst D, Zaleta A, et al. Combined treatment with cognitive behavioral therapy for insomnia and acceptance and commitment ther­apy enhances objective and subjective reports of sleep in pa­tients with advanced cancer. Psychooncology 2025; 34: e70141.
  14. Wei S, Smits MG, Tang X, Kuang L, Meng H, Ni S, et al. Efficacy and safety of melatonin for sleep onset insomnia in children and adolescents: a meta-analysis of randomized controlled tri­als. Sleep Med 2020; 68: 1-8.
  15. De Zen L, Divisic A, Molinaro G, Solidoro S, Barbi E. Dexme­detomidine at home for intractable dystonia and insomnia in children with special needs: a case series. J Pain Symptom Manage 2023; 66: e653-e657.
  16. Akard TF, Hendricks-Ferguson VL, Gilmer MJ. Pediatric pallia­tive care nursing. Ann Palliat Med 2019; 8: S39-S48.
  17. Snaman J, McCarthy S, Wiener L, Wolfe J. Pediatric palliative care in oncology. J Clin Oncol 2020; 38: 954-962.
Copyright: © 2026 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Udostępnij
without publication fees
without publication fees